Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aclaris Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ACRS
Nasdaq
8731
https://www.aclaristx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aclaris Therapeutics Inc
Aclaris Therapeutics Expands Leadership Team
- Jun 27th, 2022 11:00 am
Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
- Jun 22nd, 2022 1:40 pm
Aclaris (ACRS) Moves 5.5% Higher: Will This Strength Last?
- Jun 20th, 2022 12:20 pm
Does Aclaris (ACRS) Have the Potential to Rally 141% as Wall Street Analysts Expect?
- Jun 13th, 2022 1:55 pm
Has Aclaris Therapeutics (ACRS) Outpaced Other Medical Stocks This Year?
- Jun 6th, 2022 1:40 pm
Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference
- Jun 1st, 2022 8:01 pm
Wall Street Analysts Believe Aclaris (ACRS) Could Rally 179%: Here's is How to Trade
- May 27th, 2022 1:55 pm
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
- May 17th, 2022 3:53 pm
Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
- May 16th, 2022 11:00 am
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Misses Revenue Estimates
- May 10th, 2022 12:15 pm
Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
- May 10th, 2022 11:00 am
Lannett (LCI) Reports Q3 Loss, Lags Revenue Estimates
- May 4th, 2022 11:35 pm
Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium
- May 3rd, 2022 11:00 am
We're Hopeful That Aclaris Therapeutics (NASDAQ:ACRS) Will Use Its Cash Wisely
- May 2nd, 2022 10:10 am
FEC Resources Reports on SC 72 Force Majeure Declaration
- Apr 13th, 2022 4:17 am
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Misses Revenue Estimates
- Feb 24th, 2022 1:55 pm
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
- Feb 24th, 2022 12:00 pm
Those who invested in Aclaris Therapeutics (NASDAQ:ACRS) three years ago are up 97%
- Feb 21st, 2022 9:34 am
Earnings Preview: Aclaris Therapeutics (ACRS) Q4 Earnings Expected to Decline
- Feb 17th, 2022 8:03 pm
Did Hedge Funds Catch A Break With Aclaris Therapeutics, Inc. (ACRS)?
- Feb 6th, 2022 9:33 pm
Scroll